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S U M M A R Y 
In search of an efficient but simple, low cost procedure for the serodiagnosis of 
Toxoplasmosis, especially suited for routine laboratories facing technical and 
budget limitations as in less developed countries, the diagnostic capability of 
Hematoxo® , an hemagglutination test for toxoplasmosis, was evaluated in relation 
to a battery of tests including IgG- and IgM-immunofluorescence tests, 
hemagglutination and an IgM-capture enzymatic assay. Detecting a little as 5 I .U. of 
IgG antitoxoplasma antibodies, Hematoxo® showed a straight agreement as to 
reactivity and non-reactivity for the 443 non-reactive and the 387 reactive serum 
samples, included in this study. In 23 cases presenting a serological pattern of acute 
toxoplasmosis and showing IgM antibodies, Hematoxo® could detect IgM 
antibodies in 18, indicated by negativation or a significant decrease in titers as a 
result of treating samples with 2-mercapto-ethanol. However, a neat increase in 
sensitivity for IgM specific antibodies could be achieved by previously removing IgG 
from the sample, as demonstrated in a series of acute toxoplasmosis sera. A simple 
procedure was developed for this purpose, by reconstituting a lyophilized 
suspension of Protein A — rich Staphylococcus with the lowest serum dilution to be 
tested. 
Of low cost and easy to perform, Hematoxo® affords not only a practical 
qualitative procedure for screening reactors and non-reactors, as in prenatal 
services, but also quantitative assays that permit to titrate antibodies as well as to 
identify IgM antibodies. 
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I N T R O D U C T I O N 
Toxoplasmosis serology is a complex task 
which has begun with the description of the 
dye-test by S A B I N & F E L D M A N ^ . The next 
landmark was established by R E M I N G T O N et 
a l . i 2 j 3 by showing that IgM antibodies are an 
indication of a recent infection. Immunofluo-
recence brought such accomplishments to the 
routine laboratory. Need of standard reference 
sera to ensure reproducibility of results among 
laboratories was soon recognized11. However, 
false results in the immunofluorescence test for 
IgM antibodies were seen as frequent, false 
positives because of interfering rheumatoid 
factors5, false negatives as a consequence of 
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competition between IgG and IgM antibodies. 
A similar problem was found for the IgM-
indirect E L I S A 1 and to solve it a previous 
removal of rheumatoid factors and/or of IgG 
became obligatory. For routine purposes a 
more simple and sensitive test was described, 
the Direct Agglutination test, detecting as little 
as 2.5 I .U. of IgG antibodies7. For IgM 
antibodies, IgM-capture tests were developed, 
not subject to the referred false positive and 
false negative results. In such tests the IgM 
specific antibodies caught by an anti-IgM 
immobilized antibody can be demonstrated 
with the help of an enzyme-labeled toxoplasma 
antigen9 or through the agglutination of a 
toxoplasma suspension8. 
By following regularly a large number of 
patients with toxoplasma infection, with the 
help of a battery of tests including 
immunofluorescence tests for IgG and for IgM 
antibodies (these made specific and sensitive by 
previously removing IgG from serum) and the 
hemagglutination test, we could observe that 
usually three successive serological patterns can 
be found in the course of the infection4. Pattern 
I is seen in recent infections and shows IgM 
antibodies, together with rapidly rising titers, 
or high titers, in the IgG-immunofluorescence 
test and low, 2-mercapto-ethanol sensitive, 
hemagglutination titers. Pattern I is followed 
by Pattern I I , which shows a negative IgM-
immunofluorescence test and high-titered IgG-
immunofluorescence and hemagglutination 
tests, with hemagglutination antibodies not 
sensitive to 2-mercapto-ethanol. Pattern I I is a 
transition pattern that melts into Pattern I I I , 
which is observed in ancient or ' 'chronic'' 
toxoplasma infections and shows only low-
titered IgG-immunofluorescence and hemag­
glutination tests. 
Al l the referred technologies are available 
in developed countries but not so in underdeve­
loped ones. These face with a shortage of 
equipment, technicians and financial resources. 
In Brazil, larger and larger percentages of its 
140 million people are being reached by medical 
care, putting a serious onus on public health 
budgets. 
To cope with such growing needs, we have 
tried to standardize more simple techniques, 
with the lowest possible cost/benefit rates. In 
this way, we have been searching for practical 
but efficient tests, with low cost, stable rea­
gents, and not requiring any costly equipment. 
The hemagglutination test fulfills such 
characteristics. Performed in a plastic plate its 
results can be read by direct visual observation. 
By coating aldehyde-fixed fowl red cells 
with a total extract of toxoplasmas solubilized 
under very mild conditions, a reagent could bf 
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a - SERUM DILUTED IN S A L I N E SOLUTION 
b - SERUM DILUTED IN 0.1M 2-MERCAPTO-ETHANOL SOLUTION 
F ig . I — Examples of Hematoxo® quantitative results in toxoplasmosis serology. 
• — agglut ination 
© — no agglut ination 
o — test not done 
1 — non-reactive serum 
2 — serum reactive for I g G antibodies, titer 1:1,024 
3 — serum reactive only for I g M antibodies, titer 1:512 
4 — serum reactive both for I g G and I g M antibodies (total titer 1:8,192). 
obtained (Hematoxo® , Biolab Diagnostica, 
Brazil) that is very stable as a liquid suspension 
and sensitive both to IgG and IgM anti-toxo-
plasma antibodies2. It is able to detect as little 
as 0.3 I .U. of IgG antibodies, which corres-
ponds to 5 I.U. for a serum reactive at the 1:16 
dilution. By assaying in parallel serial serum di-
lutions, respectively in saline solution and in 
2-mercapto-ethanol 0.1M solution, different ty-
pes of results could be obtained indicating ei-
ther non-reactivity or reactivity of serum due to 
IgG antibodies, to both IgG and IgM, or only 
to IgM antibodies (Fig. 1). Significant titer dif-
ferences between the parallel series of dilutions 
indicate the presence of IgM antibodies. 
In the present study we evaluated the diag-
nostic capability of Hematoxo® hemagglutina-
tion test, in a number of serum samples for 
which diagnostic patterns of toxoplasma infec-
tion had already been established. An improve-
ment of the test was sought by a previous treat-
ment of sera with Protein A through a simple 
and practical procedure. 
M A T E R I A L A N D M E T H O D S 
Serum samples — A total of 856 serum samples 
were studied. Serum was collected from clotted 
venous blood, heat inactivated at 56°C for 30 
minutes and kept at 4°C if tested within 48 
hours. Otherwise, samples were stored at 
—20°C until assayed. 
Hemagglutination test — The test was 
performed in V-shaped wells of polystirene 
plates (Interlab, São Paulo, Brazil) by adding 
25^1 of coated cells suspension (Hematoxo® , 
Biolab Diagnostica, Brazil) to 50^1 of serum 
dilution. After mixing by vibrating or tapping 
for at least 1 minute, the plate was left at room 
temperature for 40 to 60 minutes, until positive 
and negative controls showed clear-cut 
sedimentation patterns. Tests were then read by 
direct observation, according to classical 
criteria2. For qualitative test serum was assayed 
at a 1:16 dilution, in saline solution (0.15M 
NaCl ) and in parallel in saline solution 
containing sufficient 2-mercapto-ethanol to 
provide a 0.1M final concentration. For 
quantitative tests, doubling serial dilutions in 
both diluents were tested, from 1:16 on. A titer 
difference of at least two dilutions between 
both series was taken as indicating presence of 
IgM antibodies in the sample. 
Other test for toxoplasmosis serology — 
Immunofluorescence tests were performed as 
described3 employing toxoplasma antigen and 
anti- IgG or anti-IgM heavy-chain specific 
fluorescent conjugates (Biolab, Diagnostica, 
Brazil). For the IgM-immunofluorescence test 
serum samples were previously treated with an 
IgG precipitating antibody ( R F Absorbent, 
Behringwerke, Germany) 1 5 , to avoid false 
positive and false negative results. IgM-capture 
tests10 were done in plastic plates coated with 
an anti-IgM specific monoclonal antibody 
obtained in the laboratory. As antigen was used 
a total extract of toxoplasmas and as conjugate 
the peroxidase-labeled IgG fraction of an 
antitoxoplasma polyclonal antibody obtained 
in rabbits. Extinction values, above the medium 
absorbance plus 3 standard deviations obtained 
for a large group of non-reactive sera, were 
taken as positive. 
Protein A reagent — Staphylococcus aureus, 
Cowan I strain, was grown in tryptic soy broth 
for 24 hours at 37°C under agitat ion. 
Harvested cells were washed in 0.01M 
phosphate buffered saline solution, pH 7.4, 
and the sedimented pellet suspended at \0°/o 
( V / V ) in the same solution. The suspension was 
distributed 0.3 ml per vial and lyophilized. 
R E S U L T S 
Evaluation of the diagnostic capability 
of Hematoxo® 
Hematoxo® was performed in 830 serum 
samples taken at random from the routine 
samples sent for toxoplasmosis serology. For 
these samples toxoplasmosis serological 
patterns4 were established with the help of IgG-
and IgM-immunofluorescence and IgM-capture 
immunoenzymatic tests plus titration of total 
ant i- toxoplasma antibodies by the 
hemagglutination test, as described3. Table 1 
displays Hematoxo® results according to the 
different serological patterns of the samples. As 
indicated, from the serum samples diagnosed as 
non-reactive (pattern O) , 429 were also non-
reactive for Hematoxo® . Twelve samples, 
however, were reactive when diluted in saline 
solution, with titers up to 1:64, but non-reactive 
when diluted in 0.1M 2-mercapto-ethanol 
solution. When a second sample collected from 
these patients 7 to 10 days later was tested, no 
increase in titers was observed or even negative 
results were seen. It was concluded that 
responsible antibodies corresponded to 
nonspecific "natural agglutinins ,\ In two cases 
a titer of 1:16 was seen which was not reduced 
after 2-mercapto-ethanol treatment of sera. 
Both sera were also weakly reactive in the 
Direct Agglutination test (bioMérieux, France) 
indicating presence of IgG anti-toxoplasma 
antibodies of very low titers. 
The 364 samples presenting patterns I I or 
I I I showed a positive Hematoxo® result, with 
titers that did not show any significant decrease 
after the 2-mercapto-ethanol treatment, except 
3 sera for which such a decrease was seen 
indicating presence of IgM antibodies. These 
cases had shown also low-absorbance, positive 
results, in the IgM-capture assay. 
From 23 serum samples presenting a 
Pattern I, and IgM antitoxoplasma antibodies, 
Hematoxo® was positive in 18, with titers 
from 1:64 to 1:65,536, which showed a 
significant decrease after 2-mercapto-ethanol 
treatment of sera. In 5 cases no such decrease 
was observed, probably due to the presence of 
high-titer or high-avidity IgG antibodies, which 
by competition limit the sensivity of 
Hematoxo® for IgM antibodies. 
In order to improve the test a simple 
T A B L E 1 
H E M A T O X O results in 830 serum samples classif ied according to toxoplasmosis serological patterns 
H E M A T O X O 
Serum patterns n9 non-reactive 
titers reduced 
b y 2-ME stable titers 
non-reactive 
(pattern 0) 
443 429 1 2 * 2 
acute infect ions 
(pattern I ) 
23 0 1 8 * * 5 
transit ional phase 
(pattern I I ) 
64 0 3 * * 61 
o ld infect ions 
(pattern I I I ) 
300 0 0 300 
* 1 : 1 6 - 1 : 6 4 
* * 1:64 - 1 :65 ,536 
T A B L E 2 
H E M A T O X O ® - Detect ion o f IgM antibodies in acute toxoplasmosis 
S e m m I g M - I F I g M - C A P T U R E H A / 2 - M E J^l'ar 
samples - H A / 2 - M L 
35005 256 + 2 5 6 / 3 2 64/0 
33697 16 + 1000 /256 2 5 6 / 3 2 
36235 64 + 25 6 /64 64 /0 
365 39 4000 + 2000 /32 1000 /0 
35353 1000 + 5 1 2 / 1 2 8 256 /0 
37607 1000 + 8000 /2000 8000 /64 
37619 4000 + 2000 /0 4000 /0 
37896 256 + 2000 /512 512 /0 
35623 0 + 16000/4000 64 /0 
36704 0 (±) 2000 /512 128/0 
T A B L E 3 
H E M A T O X O - Detect ion of IgM ant ibodies on ly after Protein A treatment o f sera, in acute toxoplasmosis. 
Serum 
samples 
I g M - I F * I g M - C A P T U R E H A / 2 - M E 
Prot. A 
















2 0 0 0 / 2 0 0 0 
2 0 0 0 / 2 0 0 0 
8 0 0 0 / 4 0 0 0 
4 0 0 0 / 4 0 0 0 





















5 1 2 / 2 5 6 
1000 /512 
1000 /1000 
4 0 0 0 / 2 0 0 0 


















2 0 0 0 / 2 0 0 0 
2 0 0 0 / 2 0 0 0 
2 0 0 0 / 2 0 0 0 
4 0 0 0 / 4 0 0 0 
5 1 2 / 3 2 
64/0 
5 1 2 / 0 
128/0 
T A B L E 4 
H E M A T O X O ® - Resu l ts in chron ic toxoplasmosis 
Serum 
samples 
I g M - I F I g M - C A P T U R E H A / 2 - M E 
Prot. A 


















4 0 0 0 / 4 0 0 0 
3 2 0 0 0 / 3 2 0 0 0 




2 0 0 0 / 1 0 0 0 
















1 6 0 0 0 / 1 6 0 0 0 
3 2 0 0 0 / 1 6 0 0 0 




512 /25 6 












3 2 0 0 0 / 3 2 0 0 0 
4 0 0 0 / 4 0 0 0 
8000 /8000 
2 0 0 0 / 1 0 0 0 
0 /0 
0/0 
technique was then employed to previously 
reduce the IgG concentration in the tested 
samples. 
For this purpose, a vial of lyophilized 
Staphylococcus rich in Protein A was 
reconstituted with the sample to be assayed, 
diluted 1:16 in saline solution. After 1 hour 
under low agitation at room temperature, the 
reconstituted suspension was centrifuged at 
about 2000 xg for 10 minutes and supernatant 
diluted in parallel doubling series, in saline 
solution and in 0.1M 2-mercapto-ethanol and 
the test done as previously indicated. Table 2 
shows Hematoxo® results, before and after 
Protein A treatment of sera, in cases presenting 
a positive IgM-capture test. Although a 
significant decrease in the hemagglutination 
titers had already indicated presence of IgM 
antibodies, results were significantly more 
evident after Protein A treatment of sera. In 
Table 3, such results were evident only after 
such treatment. Table 4 includes sera presenting 
T A B L E 5 
H E M A T O X O " - Fa lse results in the detect ion o f ant i - toxoplasma IgM antibodies 
Serum I g M - I F I g M - C A P T U R E H A / 2 - M E 
Prot. A 


















4 0 0 0 / 4 0 0 0 
4 0 0 0 / 4 0 0 0 
1000 /1000 
2 0 0 0 / 2 0 0 0 






negative results in the IgM-immunofluorescen-
ce and IgM-capture tests. No significant titer 
decreases were seen in Hematoxo® , even after 
Protein A treatment of sera. In Table 5 are 
shown two IgM-positive cases, for which 
Hematoxo® was negative even after Protein A 
treatment of the samples. It shows also 3 cases 
with no IgM in which negativation of a positive 
Hematoxo® was seen after such treatment. 
However, titers observed were low, of 1:64 or 
less. 
D I S C U S S I O N 
According to our results H E M A T O X O ® 
shows a high diagnostic capability in 
toxoplasmosis serology, since displaying high 
sensitivity to detect IgG anti-toxoplasma 
antibodies (5 I .U./ml) 2 and able to detect IgM 
specific antibodies. Previously treating samples 
with 2-mercapto-ethanol resulted in a complete 
negativation of the tests in most cases that 
presented a serological pattern of a recent 
infection (pattern I ) , or striking titer decreases 
when high titers were already observed. In this 
way, IgM antibodies could be detected in 18 out 
of 25 cases showing pattern I. As previously 
demonstrated for immunofluorescence and 
hemagglutination tests 6 , sensitivity of 
Hematoxo® to IgM antibodies could be 
improved by reducing IgG concentration in the 
tested sera by previously treating samples with a 
suspension of Protein A rich Staphylococcus 
aureus. In the present study this procedure 
could be simpl i f ied for use in routine 
laboratories by reconstituting a lyophilized 
Staphylococcus suspension with the lowest 
serum dilution to be assayed. 
In non-reactive samples, Hematoxo® 
occasionally showed false positive results for 
IgM antibodies. These were due to "natural 
agglutinins" or non-specific IgM antibodies, 
which could be distinguished from the specific 
ones because showing low titers, not exceeding 
1:64, usually of 1:16. In acute toxoplasmosis, 
on the contrary, titers were in general much 
higher, of 1:512 or more, or when low, a 
definite increase was seen for a second serum 
sample collected a few days later, when IgG 
antibodies may also be detected. In this way, 
Hematoxo® results permitted to identify the 
different toxoplasmosis serological stages. IgM 
antibodies could be easily evidenced in acute 
toxoplasmosis. In transitional stages, high titers 
O4.000) were seen due to IgG and eventually to 
"residual' ' IgM antibodies as observed also for 
IgM-capture tests. In chronic toxoplasmosis 
results indicated only low-titered IgG 
antibodies. 
Hematoxo® is thus a simple, low-cost 
technique, adequate for routine laboratories 
and able to define a serological diagnosis of 
toxoplasma infection. It affords not only a 
practical qualitative procedure for screening 
reactors and non-reactors, as in prenatal 
services, but also quantitative assays that 
permit to titrate IgG antibodies as well as to 
identify IgM antibodies. 
R E S U M O 
Procedimento adequado para a sorologia da to-
xoplasmose utilizando um teste de hemagluti-
nação capaz de detectar anticorpos IgG e IgM 
Avaliou-se o teste de hemaglutinação 
Hematoxo® , associado ou não à prévia remo-
ção de IgG do soro pela Proteína A , como pro-
cedimento de rotina para o diagnóstico soroló-
gico da toxoplasmose. A capacidade diagnosti-
ca do teste foi investigada em soros já classifi-
cados por uma bateria de testes, de imunofluo-
rescência, hemaglutinação e imunoenzimático 
de captura de IgM, segundo os diferentes perfis 
sorológicos observados na toxoplasmose. 
Revelando desde 5 U. I . de anticorpos IgG 
por mililitro de soro, Hematoxo® evidenciou 
estreita concordância quanto à reatividade e 
não reatividade em 443 soros não reagentes e 
387 soros reagentes. De 23 casos de toxoplas-
mose aguda com perfil I , o teste de hemagluti-
nação detectou anticorpos IgM em 18, pela ne-
gativação ou queda significativa de títulos após 
tratamento das amostras com 2-mercapto-
etanol. Porém, obteve-se nítido aumento da 
sensibilidade do teste Hematoxo® para anti-
corpos IgM removendo-se IgG das amostras. 
Para esse fim reconstituiu-se uma suspensão 
liofilizada de estafilococos produtores de Pro-
teína A corn a diluição do soro, que depois de 
centrifugada era utilizada no teste. 
Desse modo, Hematoxo® , como teste 
qualitativo, mostrou-se adequado para a identi-
ficação de reatores e não reatores, por exemplo, 
na triagem de gestantes de risco. Como teste 
quantitativo, permitiu o diagnóstico das várias 
fases sorológicas da toxoplasmose, pela titula-
ção de anticorpos IgG e pela evidenciação de 
anticorpos IgM. De realização simples e baixo 
custo, Hematoxo® mostra-se um teste adequa-
do para a rotina diagnostica. 
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